Evidence map›Paper›PMID 37521794›Full record

ArticleACS central science2023

Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents.

Jesse M McFarland, Maša Alečković, George Coricor, Sangeetha Srinivasan, Matthew Tso, John Lee, Tri-Hung Nguyen, José M Mejía Oneto

Open access · diamondAbstract read
In one paragraph

Article in ACS central science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Click-to-Release Reactions for Tertiary Amines and Pyridines.Journal of the American Chemical Society · 2026
    Article
  6. Article
  7. Article
  8. Development of a First-in-Class Click Chemistry-Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  9. Toward Realization of Bioorthogonal Chemistry in the Clinic.Topics in current chemistry (Cham) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Synthesis of CThe Journal of organic chemistry · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Senolysis Enabled by Senescent Cell-Sensitive Bioorthogonal Tetrazine Ligation.Angewandte Chemie (International ed. in English) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jesse M McFarlandShasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States.ORCID https://orcid.org/0000-0003-2393-3789
Maša AlečkovićShasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States.
George CoricorShasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States.
Sangeetha SrinivasanShasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States.
Matthew TsoShasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States.
John LeeShasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States.
Tri-Hung NguyenShasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States.
José M Mejía OnetoShasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Click Activated Protodrugs Against Cancer (CAPAC) platform enables the activation of powerful cancer drugs at tumors. CAPAC utilizes a click chemistry reaction between tetrazine and

Identifiers

PMID37521794
PMCPMC10375897
OpenAlexW4381805892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.